Opportunistic fungal infection is a rare but severe complication in allogeneic bone marrow transplant (BMT) recipients. We report a 49-year-old patient who developed pneumonitis after BMT, due to a Mucorales fungus (class Zygomycetes), Absidia corymbifera. Infections due to mucormycosis are likely to become increasingly recognized even though the occurrence after BMT has only been described sporadically. We postulate that the patient was contaminated before BMT despite no intensive drug treatment or other iatrogenic features, related to his poor living conditions and developed the infection during aplasia. He immediately received i.v. liposomal amphotericin B (AmBisome) and GM-CSF. Because there was no response, the infected area and necrotic tissue were resected. Despite initial clinical and biological improvement and the absence of Mucor on mycological examination post-surgery, the patient died 3 weeks later from bilateral pulmonary infection and multiorgan failure.
Opportunistic fungal infections frequently occur in hematology patients and are usually due to yeast, mostly Candida. Infection by filamentous fungi is rare but serious, especially when due to Aspergillus. 1 Mucormycosis occurs infrequently compared to aspergillosis, but has the same poor prognosis and the same risk factors in patients severely immunosuppressed with hematological malignancies and receiving a BMT. Even though its occurrence after BMT has only been described sporadically, recently, mucormycosis has been increasingly recognized, and is usually due to Rhizopus arrhizus. 2 Absidia corymbifera, an ubiquitous opportunistic fungal agent, is the only pathogenic mould of Absidia genera. In immunocompetent hosts, the hyphae and spores of mucormycosis cause negligible pathology, but can cause aggressive and fulminant disease in immunosuppressed patients. We report a case of mucormycosis localized to the lung with invasion of blood vessels by hyphae, resulting in tissue necrosis and hemorrhage, developing within 100 days, in a 49-year-old man who underwent allogeneic BMT. Fungus was observed on bronchial lavage (BAL) and in histological samples after surgical resection, identified by mycological examinations and cultures. Infection caused by Absidia corymbifera is exceedingly rare, accounting for less than 1% of reported cases, 3 and has never been documented isolated to the lung. We confirm the importance of rapid treatment with i.v. liposomal amphotericin B and growth factors (GM-CSF) in combination with surgical management to improve local control. Unfortunately, despite the initial clinical improvement and the absence of Mucor on mycological examination after surgery, the patient died 3 weeks later from a bilateral pulmonary infection and multi-organ failure.
Case report
A 49-year-old unemployed man of poor social background was diagnosed with Ph1-negative chronic myelogenous leukemia (CML). He was first treated with interferon and hydroxyurea, with no reduction in the size of the spleen and white blood count (WBC). Allogeneic BMT was performed from his HLA-identical sister after conditioning with cyclophosphamide and busulfan. Cyclosporine and methotrexate were used as graft-versus-host disease (GVHD) prophylaxis. He was isolated in a HEPA-filtered room from day −1 prior to transplant and received prophylactic systemic anti-fungal treatment with intravenous fluconazole (100 mg/day).
On day +15, when the WBC was 0.1 × 10 9 /l a non-specific focal febrile pneumonitis of the lower right lung with a pleural effusion was diagnosed clinically. Sputum and blood cultures were repeatedly negative, and stool cultures remained positive for Candida glabrata. He was started on piperacillin-tazobactam and amikacine. On day +17 he had a recurrent fever. Chest radiography remained unchanged, and sputum and blood cultures were still negative; vancomycin was added.
On day +20, bronchoscopy with BAL was performed. Direct examination after centrifugation of the BAL was negative. However, cultures showed broad, septate hyphae ( Figure 1 ) which grew on Sabouraud agar media with antibacterial antibiotics. The culture plates were incubated at 25 and 37°C. Colonies were fast growing, initially white, becoming pale gray after 1 week. Spongiophores were hyaline, single or sometimes branched, arising from the stolons, in groups of three, or in whorls of up to five. Sporangia were typically pyriform in shape with a characteristic conical-shaped columella and pronounced apophysis ( Figure 2 ). All of these characteristics suggested a diagnosis of Absidia corymbifera. A Candida glabrata was also isolated from the BAL, and identified by API 32 C system (Bio-Mérieux, Lyon, France). In vitro antifungal susceptibility testing was performed using a micromethod according to NCCLS recommendations. This showed sensitivity to Amphotericin B (MIC Ͻ1.25 g/ml), but resistance to azoles agents. No mould was found in the pleural effusion. Intravenous liposomal amphotericin B (5 mg/kg/day) was started on day +20 along with intravenous granulocytemonocyte colony-stimulating factor (GM-CSF), to hasten neutrophil and macrophage recovery. On day +21, an enhanced pulmonary ( Figure 3 ) and mediastinal chest CT scan was performed which confirmed the focal unilateral lesion with bilateral pleural effusions. It also showed invasion of the vasculature with necrotic tissue indicating a high risk of vascular rupture. Cerebral CT scan was normal but abdominal scan showed splenic infarcts.
CT of the chest was repeated every 2 days and showed no evolution with a persisting high risk of hemorragic infarction and sudden death (Figure 4) . Thus, despite severe pancytopenia (WBC at 0.2 × 10 9 /l, hemoglobin at 8 g/dl, and 50 × 10 9 /l platelets, and moderate renal failure) extensive surgery to resect the right middle and lower lobes was carried out on day 30. Histological examination and mycological culture of biopsies, confirmed the diagnosis of zygomycosis due to Absidia corymbifera, together with Candida glabrata. The patient remained in the post-surgical intensive care ward receiving liposomal amphotericin B and GM-CSF. He was clinically stable, and his WBC reached 1.5 × 10 9 /l, and absolute granulocyte count 0.5 × 10 9 /l, with correction of the renal parameters.
On day +45, an extensive right lung pneumonitis reappeared, confirmed on chest radiography, without recurrence of Mucormycosis on the second BAL. However, Candida glabrata persisted. He had a delayed recovery of his neutrophils together with renal insufficiency and liver abnormalities. Ventilation was required. He died on day +52 from multi-organ failure with bilateral infection of the lungs; autopsy was not undertaken.
Discussion
Absidia corymbifera, the only pathogenic fungus of the Absidia genera, is an ubiquitous opportunistic agent from the order Mucorales (class Zygomycetes), found in air, soil and food. In this case, the origin of the infection was unknown; thus we postulated that this patient had a preexisting focus of infection perhaps in relation to his particularly poor living style. Infections caused by Absidia corymbifera are exceedingly rare. 3 Less than 1% of cases have been described to date, and those reported never mention the occurrence of this fungus isolated in the lung where the most frequent mucor is Rhizopus arrhizus. One study 3 showed that localized sinonasal disease or CNS disease is more common in BMT recipients as a consequence of hematogenous dissemination from the lung because of the rapidly progressive nature of this infection. Inhalation of spores with subsequent hematogenous dissemination is thought to occur in immunocompromised hosts. However, none of our other patients suffered from mucormycoses in the past. From an epidemiological point of view, the incidence of mucormycoses in such immunocompromised patients is lower than that caused by other phyllophane fungi such as Aspergillus spp. This incidence may be explained by the ecology of this fungi and differences between the relative abundance of fungal spores in indoor air. Numerous studies on microbial evaluation of indoor environments have shown that the most frequently isolated fungi were: Penicillium spp., Cladosporium spp., Aspergillus spp.; however, Mucor species were rarely isolated. 4 In our case, air sampling performed with an Andersen apparatus (Andersen 2000, Atlanta, GA, USA) was carried out in both the ward and the patient's room and did not reveal the presence of this fungus. As in most cases described, 3 it was particularly hard to initially diagnose this infection, and recognition of these rare infections requires a high index of suspicion: the infection usually develops within the first 100 days post-BMT. 2 Patients are predisposed individuals with some of the main risk factors.
2 However, our patient was not diabetic, had never received steroids or been aplastic, having only been treated with interferon and hydroxyurea. Clinical signs which should alert physicians include unremitting fever despite broad-spectrum antibacterial treatment and progression of lung infiltrates regardless of the radiological presentation. However, none of these characteristics are specific.
From a mycological point of view, when Mucor species have been isolated from aspirated material, the results should be interpreted with caution because these species are also common contaminants in the mycological laboratory. Therefore, the demonstration of broad coenocytic hyphae in histological samples is considered more significant than isolation after culture.
As previously reported, 5 effective systemic anti-fungal treatment was rapidly administered (i.v. liposomal amphotericin B (5 mg/kg per day)), to allow better penetration into cells 6 and the possibility of increasing the dose with a reduced chance of side-effects and kidney failure. 7 We also gave granulocyte-monocyte colony-stimulating factor (GM-CSF) to hasten neutrophil and macrophage recovery and stimulate macrophage function against fungi. Multiple studies have shown that despite the introduction of numerous agents with definite antifungal activity, little success has, as yet, been seen in the treatment of mycoses such as Aspergillosis or Mucormycosis. Some cases 8, 9 have illustrated that anatomical resection may improve local disease control and can be carried out with an acceptable risk, whether the infection be of cutaneous, sinonasal, pulmonary or CNS origin. Several factors in this case led us to perform surgery on this BMT recipient. First, every 2 days, chest CT scan showed stable but non-regressive disease after 10 days treatment with i.v. liposomal amphotericin B, resulting in a persistent high risk of subsequent hemoptysis and sudden death. Next, the patient had rejected the donor marrow despite growth factors, and, as a result, had delayed recovery of his own neutrophil count. This further increased the risk of dissemination. There was, finally, moderate renal failure due to cyclosporin, aminoside, vancomicin and liposomal amphotericin B, all known for their cumulative renal toxicity.
The case reported here serves to emphasize that poor social standards can be a risk factor and we questioned the place of systemic antifungal prophylactic treatment with i.v. liposomal amphotericin B.
10,11 Despite a high level of suspicion, quick diagnosis, early treatment with systemic antifungals, growth factors and local surgical control of the infection, the mortality rate is still high. This patient died from respiratory failure in the context of multi-organ failure, acute hepatic GVHD, and drug-induced kidney failure. The Mucor appeared to have been cleared because none was isolated from the second BAL. Thus, the presence of Candida glabrata was probably an invasive reinfection because no other organism was found to explain the extensive pneumonitis. However, the Candida glabrata seen on the second BAL remained although sensitive in vitro to amphotericin B given in adequate doses and never stopped.
